Launch of India's First Indigenous CRISPR Gene Therapy for Sickle Cell Disease
Union Minister Dr. Jitendra Singh has launched 'BIRSA 101', India's first indigenous CRISPR-based gene therapy aimed at treating Sickle Cell Disease, particularly affecting tribal populations. This initiative marks a significant step towards a Sickle Cell-free India by 2047, aligning with the Prime Minister's vision and the Atmanirbhar Bharat initiative. The therapy, developed by CSIR-IGIB, promises affordability and accessibility, especially for underserved communities, and is dedicated to the legacy of tribal freedom fighter Bhagwan Birsa Munda.
Source: Original Link